2023 - Research.com Medicine in Japan Leader Award
2023 - Research.com Biology and Biochemistry in Japan Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Biology and Biochemistry in Japan Leader Award
Shuh Narumiya spends much of his time researching Cell biology, Receptor, Molecular biology, Endocrinology and Internal medicine. The concepts of his Cell biology study are interwoven with issues in MDia1, Actin cytoskeleton and Cytokinesis. His Receptor research is multidisciplinary, incorporating elements of Prostaglandin E and Prostaglandin.
The various areas that Shuh Narumiya examines in his Molecular biology study include Kinase, Protein kinase A, Complementary DNA, cDNA library and Serine/threonine-specific protein kinase. Shuh Narumiya does research in Internal medicine, focusing on Thromboxane specifically. His work deals with themes such as Cancer research and Immunology, which intersect with Prostaglandin E2.
Receptor, Internal medicine, Cell biology, Endocrinology and Prostaglandin are his primary areas of study. His Receptor research incorporates elements of Inflammation and Immunology. His biological study spans a wide range of topics, including MDia1, Formins, Actin cytoskeleton and Cytokinesis.
His Endocrinology research includes themes of Thromboxane and Thromboxane A2. Shuh Narumiya has included themes like Anesthesia and Pharmacology in his Prostaglandin study. His study focuses on the intersection of Biochemistry and fields such as Molecular biology with connections in the field of Complementary DNA and Protein kinase A.
His primary areas of investigation include Receptor, Immunology, Inflammation, Cell biology and Internal medicine. Shuh Narumiya combines subjects such as Prostaglandin and Pharmacology with his study of Receptor. His research investigates the connection between Immunology and topics such as Hepatic stellate cell that intersect with issues in Hepatocyte.
His Inflammation study combines topics from a wide range of disciplines, such as Prostaglandin E2, Cancer research, Cytokine and Innate immune system. His Cell biology study also includes
Shuh Narumiya focuses on Inflammation, Immunology, Receptor, Cell biology and Cancer research. His work carried out in the field of Immunology brings together such families of science as Hepatic stellate cell, Prostaglandin E2, Matrix metalloproteinase, Acute kidney injury and Fibroblast. His Receptor study incorporates themes from Prostaglandin and Neuroscience, Social defeat.
His Cell biology research is mostly focused on the topic NF-κB. His Cancer research study deals with Tumor microenvironment intersecting with Gut flora and HCCS. Within the field of Internal medicine and Endocrinology he studies Prostaglandin E.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prostanoid Receptors: Structures, Properties, and Functions
Shuh Narumiya;Yukihiko Sugimoto;Fumitaka Ushikubi.
Physiological Reviews (1999)
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
Masayoshi Uehata;Toshimasa Ishizaki;Hiroyuki Satoh;Takashi Ono.
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Robert A. Coleman;William L. Smith;Shuh Narumiya.
Pharmacological Reviews (1994)
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Yoshiya Kawaguchi;Toshihiro Okamoto;Masafumi Taniwaki;Megumi Aizawa.
Nature Genetics (1994)
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
Midori Maekawa;Toshimasa Ishizaki;Shuken Boku;Naoki Watanabe.
Focal Contacts as Mechanosensors Externally Applied Local Mechanical Force Induces Growth of Focal Contacts by an Mdia1-Dependent and Rock-Independent Mechanism
Daniel Riveline;Daniel Riveline;Eli Zamir;Nathalie Q. Balaban;Ulrich S. Schwarz.
Journal of Cell Biology (2001)
Prostaglandin E Receptors
Yukihiko Sugimoto;Shuh Narumiya.
Journal of Biological Chemistry (2007)
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
Toshimasa Ishizaki;Masayoshi Uehata;Ichiro Tamechika;Jeongsin Keel.
Molecular Pharmacology (2000)
The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase.
Toshimasa Ishizaki;Midori Maekawa;Kazuko Fujisawa;Katsuya Okawa.
The EMBO Journal (1996)
p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin.
Naoki Watanabe;Pascal Madaule;Tim Reid;Toshimasa Ishizaki.
The EMBO Journal (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: